-
1
-
-
0032886561
-
Essential drugs for infants and children: North American perspective
-
Kauffman RE. Essential drugs for infants and children: North American perspective. Pediatrics 1999; 104 (3 Pt 2): 603-5
-
(1999)
Pediatrics
, vol.104
, Issue.3 PART 2
, pp. 603-605
-
-
Kauffman, R.E.1
-
2
-
-
0037374394
-
Use of healthy children as volunteers in drug studies: The ethical debate
-
Koren G, Kearns GL, Reed M, et al. Use of healthy children as volunteers in drug studies: the ethical debate. Clin Pharmacol Ther 2003; 73 (3): 147-52
-
(2003)
Clin Pharmacol Ther
, vol.73
, Issue.3
, pp. 147-152
-
-
Koren, G.1
Kearns, G.L.2
Reed, M.3
-
3
-
-
0037206361
-
Testing medications in children
-
Steinbrook R. Testing medications in children. N Engl J Med 2002; 347 (18): 1462-70
-
(2002)
N Engl J Med
, vol.347
, Issue.18
, pp. 1462-1470
-
-
Steinbrook, R.1
-
4
-
-
0037350150
-
Research in children
-
Burns JP. Research in children. Crit Care Med 2003; 31 (3 Suppl.): S131-6
-
(2003)
Crit Care Med
, vol.31
, Issue.3 SUPPL.
-
-
Burns, J.P.1
-
6
-
-
0035016127
-
Pharmacogenetics and pharmacogenomics
-
Leeder JS. Pharmacogenetics and pharmacogenomics. Pediatr Clin North Am 2001; 48 (3): 765-81
-
(2001)
Pediatr Clin North Am
, vol.48
, Issue.3
, pp. 765-781
-
-
Leeder, J.S.1
-
7
-
-
0034051263
-
Brassica vegetables increase and apiaceous vegetables decrease cytochrome P450 1A2 activity in humans: Changes in caffeine metabolite ratios in response to controlled vegetable diets
-
Lampe JW, King IB, Li S, et al. Brassica vegetables increase and apiaceous vegetables decrease cytochrome P450 1A2 activity in humans: changes in caffeine metabolite ratios in response to controlled vegetable diets. Carcinogenesis 2000; 21 (6): 1157-62
-
(2000)
Carcinogenesis
, vol.21
, Issue.6
, pp. 1157-1162
-
-
Lampe, J.W.1
King, I.B.2
Li, S.3
-
8
-
-
0023152266
-
Delay in caffeine elimination in breast-fed infants
-
Le Guennec JC, Billon B. Delay in caffeine elimination in breast-fed infants. Pediatrics 1987; 79 (2): 264-8
-
(1987)
Pediatrics
, vol.79
, Issue.2
, pp. 264-268
-
-
Le Guennec, J.C.1
Billon, B.2
-
9
-
-
0034737962
-
What makes clinical research ethical?
-
Emanuel EJ, Wendler D, Grady C. What makes clinical research ethical? JAMA 2000; 283 (20): 2701-11
-
(2000)
JAMA
, vol.283
, Issue.20
, pp. 2701-2711
-
-
Emanuel, E.J.1
Wendler, D.2
Grady, C.3
-
10
-
-
0345920891
-
-
45 CFR §46.404-407, 2003
-
45 CFR §46.404-407, 2003
-
-
-
-
11
-
-
0037329681
-
Do healthy children deserve greater protection in medical research?
-
Ross LF. Do healthy children deserve greater protection in medical research? J Pediatr 2003; 142 (2): 108-12
-
(2003)
J Pediatr
, vol.142
, Issue.2
, pp. 108-112
-
-
Ross, L.F.1
-
12
-
-
0037329077
-
Informed consent for pediatric research: Is it really possible?
-
Kodish E. Informed consent for pediatric research: is it really possible? J Pediatr 2003; 142 (2): 89-90
-
(2003)
J Pediatr
, vol.142
, Issue.2
, pp. 89-90
-
-
Kodish, E.1
-
13
-
-
0028872836
-
Points to consider: Ethical, legal, and psychosocial implications of genetic testing in children and adolescents
-
American Society of Human Genetics Board of Directors, American College of Medical Genetics Board of Directors. Points to consider: ethical, legal, and psychosocial implications of genetic testing in children and adolescents. Am J Hum Genet 1995; 57 (5): 1233-41
-
(1995)
Am J Hum Genet
, vol.57
, Issue.5
, pp. 1233-1241
-
-
|